PapersFlow Research Brief

Life Sciences · Pharmacology, Toxicology and Pharmaceutics

Advancements in Transdermal Drug Delivery
Research Guide

What is Advancements in Transdermal Drug Delivery?

Advancements in transdermal drug delivery are innovations in systems that enable drugs to pass through the skin barrier for systemic or local effects, including solid lipid nanoparticles, microneedles, skin penetration enhancers, nanostructured lipid carriers, and microemulsion-based formulations.

Research encompasses 50,799 works on overcoming the skin's stratum corneum barrier to enhance permeation. Key approaches involve solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and microemulsions for controlled release. Prausnitz and Langer (2008) in "Transdermal drug delivery" outline methods to bypass skin barriers for effective delivery.

Topic Hierarchy

100%
graph TD D["Life Sciences"] F["Pharmacology, Toxicology and Pharmaceutics"] S["Pharmaceutical Science"] T["Advancements in Transdermal Drug Delivery"] D --> F F --> S S --> T style T fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan
50.8K
Papers
N/A
5yr Growth
1.2M
Total Citations

Research Sub-Topics

Why It Matters

Transdermal systems improve bioavailability of poorly soluble drugs by protecting them from degradation, as lipidic nanocarriers incorporate lipophilic and hydrophilic molecules (Danaei et al. 2018, "Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems"). SLN enable controlled drug release in dermatological applications (Müller et al. 2002, "Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations"). Microemulsions serve as novel media for drug delivery, enhancing skin permeation (Lawrence and Rees 2000, "Microemulsion-based media as novel drug delivery systems"). These advancements support applications in cosmetics and therapeutics by addressing skin barrier function.

Reading Guide

Where to Start

"Transdermal drug delivery" by Prausnitz and Langer (2008) provides foundational mechanisms of skin permeation and delivery methods, serving as an accessible entry for understanding barrier challenges.

Key Papers Explained

Prausnitz and Langer (2008) "Transdermal drug delivery" establishes skin barrier basics, which Müller (2000) "Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art" builds on with SLN for controlled release. Mehnert (2001) "Solid lipid nanoparticles Production, characterization and applications" details SLN production, extending to Danaei et al. (2018) "Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems" on optimization. Müller et al. (2002) "Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations" applies these to dermatology, linking back to foundational permeation.

Paper Timeline

100%
graph LR P0["Mechanism of sustained‐action me...
1963 · 4.7K cites"] P1["Mechanisms of solute release fro...
1983 · 4.9K cites"] P2["Capillary flow as the cause of r...
1997 · 6.2K cites"] P3["Solid lipid nanoparticles SLN ...
2000 · 3.7K cites"] P4["Solid lipid nanoparticles Produc...
2001 · 3.1K cites"] P5["Transdermal drug delivery
2008 · 3.3K cites"] P6["Impact of Particle Size and Poly...
2018 · 4.1K cites"] P0 --> P1 P1 --> P2 P2 --> P3 P3 --> P4 P4 --> P5 P5 --> P6 style P2 fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan

Most-cited paper highlighted in red. Papers ordered chronologically.

Advanced Directions

Focus shifts to nanostructured lipid carriers and microemulsions for enhanced stability, as in top-cited reviews, with emphasis on particle metrics for clinical translation. No recent preprints available, so prioritize polydispersity impacts from Danaei et al. (2018).

Papers at a Glance

# Paper Year Venue Citations Open Access
1 Capillary flow as the cause of ring stains from dried liquid d... 1997 Nature 6.2K
2 Mechanisms of solute release from porous hydrophilic polymers 1983 International Journal ... 4.9K
3 Mechanism of sustained‐action medication. Theoretical analysis... 1963 Journal of Pharmaceuti... 4.7K
4 Impact of Particle Size and Polydispersity Index on the Clinic... 2018 Pharmaceutics 4.1K
5 Solid lipid nanoparticles (SLN) for controlled drug delivery â... 2000 European Journal of Ph... 3.7K
6 Transdermal drug delivery 2008 Nature Biotechnology 3.3K
7 Solid lipid nanoparticles Production, characterization and app... 2001 Advanced Drug Delivery... 3.1K
8 METHODS FOR THE STUDY OF IRRITATION AND TOXICITY OF SUBSTANCES... 1944 Journal of Pharmacolog... 2.6K
9 Solid lipid nanoparticles (SLN) and nanostructured lipid carri... 2002 Advanced Drug Delivery... 2.0K
10 Microemulsion-based media as novel drug delivery systems 2000 Advanced Drug Delivery... 2.0K

Frequently Asked Questions

What are solid lipid nanoparticles in transdermal delivery?

Solid lipid nanoparticles (SLN) are used for controlled drug delivery, as reviewed in the state of the art (Müller 2000, "Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art"). They provide production, characterization, and applications for enhanced skin permeation (Mehnert 2001, "Solid lipid nanoparticles Production, characterization and applications"). SLN and NLC appear in cosmetic and dermatological preparations (Müller et al. 2002).

How do lipidic nanocarriers affect drug bioavailability?

Lipidic nanocarriers enhance bioavailability of poorly-soluble drugs by incorporating lipophilic and hydrophilic molecules and protecting against degradation. Particle size and polydispersity index impact their clinical applications (Danaei et al. 2018, "Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems"). These carriers address skin barrier challenges in transdermal systems.

What methods improve transdermal drug delivery?

Transdermal drug delivery employs techniques to overcome the skin barrier, including chemical enhancers and physical methods (Prausnitz and Langer 2008, "Transdermal drug delivery"). Innovations like microneedles and iontophoretic delivery enhance skin permeation. The field focuses on stratum corneum disruption for effective drug release.

What role do microemulsions play in drug delivery?

Microemulsions act as novel drug delivery systems for transdermal applications (Lawrence and Rees 2000, "Microemulsion-based media as novel drug delivery systems"). They improve solubility and skin penetration. These systems support sustained release mechanisms.

How is skin irritation assessed in topical delivery?

Methods for studying irritation and toxicity of topically applied substances involve standardized testing on skin and mucous membranes (Draize et al. 1944, "METHODS FOR THE STUDY OF IRRITATION AND TOXICITY OF SUBSTANCES APPLIED TOPICALLY TO THE SKIN AND MUCOUS MEMBRANES"). These protocols evaluate safety in transdermal formulations. They remain relevant for nanocarrier assessments.

Open Research Questions

  • ? How can particle size and polydispersity of lipidic nanocarriers be optimized for consistent transdermal permeation?
  • ? What production methods for SLN and NLC maximize drug loading while minimizing skin irritation?
  • ? Which skin penetration enhancers most effectively disrupt the stratum corneum without toxicity?
  • ? How do microemulsion compositions influence sustained release rates across diverse drug types?

Research Advancements in Transdermal Drug Delivery with AI

PapersFlow provides specialized AI tools for Pharmacology, Toxicology and Pharmaceutics researchers. Here are the most relevant for this topic:

See how researchers in Life Sciences use PapersFlow

Field-specific workflows, example queries, and use cases.

Life Sciences Guide

Start Researching Advancements in Transdermal Drug Delivery with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Pharmacology, Toxicology and Pharmaceutics researchers